Keyphrases
T Cells
86%
Neuroblastoma
66%
MHC Class II
50%
Natural Killer Cells
49%
T Cell Receptor
40%
Cord Blood
37%
Organoids
37%
Engineered T Cells
29%
High-risk Neuroblastoma
29%
MHC Class I
28%
Cancer Immunotherapy
28%
In Cancer
28%
Cell Lineage
28%
Tumor Cells
25%
CD8+ T Cells
24%
Relapsed or Refractory Acute Myeloid Leukemia
23%
Cellular Immunotherapy
21%
Cell Therapy
21%
Tumor
21%
Immunogenicity
21%
Dendritic Cells
18%
Integrative Analysis
18%
TIGIT
18%
MR1T
18%
Nectin-2
18%
Single-cell RNA Sequencing (scRNA-seq)
18%
Pediatric Tumors
18%
Cas9 Protein
18%
T Cell Recognition
18%
Pediatric
18%
Cell Tumor
18%
Cellular Products
18%
Imaging Platform
18%
Lineage Switch
18%
3D Live Imaging
18%
Cell Behavior
18%
Pediatric Cancer
18%
Tumor Response
18%
Behavioral Response
18%
Epigenetic Modulation
18%
Immune Cells
18%
Adoptive Cell Therapy
16%
Solid Tumors
16%
Histone Deacetylase Inhibitor (HDACi)
15%
Wilms Tumor
15%
Immune Monitoring
14%
Mode of Action
14%
Human Leukocyte Antigen
14%
Embryonal Tumor
14%
Drug Library Screening
12%
Immunology and Microbiology
T Cell
100%
Immunotherapy
66%
Organoid
48%
Natural Killer Cell
47%
T Cell Receptor
33%
Major Histocompatibility Complex
28%
Cell Lineage
28%
Cancer Immunotherapy
28%
Tumor Cell
26%
Myeloid
25%
B Cell
25%
Cytotoxicity
23%
Immunogenicity
21%
Immunocompetent Cell
21%
Cell Function
20%
Coculture
19%
Chimeric Antigen Receptor T-Cell
19%
RNA Sequence
18%
CRISPR/Cas9
18%
Death Receptor
18%
P53
18%
Precursor
18%
CD19
18%
Immunology
14%
Immunity
14%
Programmed Death-Ligand 1
12%
Cytotoxic T-Cell
12%
Immune Response
12%
Adherent Cell
12%
Chimeric Antigen Receptor T-Cell Therapy
11%
Hematopoietic Cell
11%
MHC Class I
9%
Lineages
9%
Downregulation
9%
Staining
9%
Dendritic Cell
9%
Intravenous Immunoglobulin
9%
Neuroblastoma Cell
8%
Neuroblastoma Cell Line
8%
Cell Line
7%
Survival Rate
6%
Cytokine
6%
Histone
6%
High Throughput Screening
6%
Dynamics
6%
Immunosuppressive Drug
6%
Natural Killer T Cell
6%
Syngenic
6%
Gene Expression Assay
5%
Medicine and Dentistry
T Cell
79%
Ganglioneuroblastoma
49%
Immunotherapy
45%
T Lymphocyte Receptor
35%
Organoid
28%
Clustered Regularly Interspaced Short Palindromic Repeat
28%
Cord Blood
28%
Pediatrics
25%
Natural Killer Cell
23%
RNA Sequence
21%
Cell Therapy
21%
Neoplasm
20%
Major Histocompatibility Complex
20%
Dendritic Cell
18%
Pediatric Cancer
18%
Tumor Cell
18%
Cas9
18%
Cell Lineage
18%
Immunogenicity
18%
Acute Myeloid Leukemia
18%
Cytotoxicity
18%
Cytotoxic T-Cell
13%
B Cell
13%
In Vitro
12%
Hematopoietic Cell
12%
Adherent Cell
11%
Flow Cytometry
11%
Histone Deacetylase Inhibitor
11%
Wilms' Tumor
11%
T Cell Receptor
11%
Malignant Neoplasm
11%
Receptor Expression
10%
Chimeric Antigen Receptor T-Cell
10%
CRISPR Associated Protein
9%
Hematologic Malignancy
9%
Human Leukocyte Antigen
9%
Leukemia
9%
Protein P53
9%
Death Receptor
9%
Precursor
9%
Acute Lymphoblastic Leukemia
9%
Survival Rate
7%
Programmed Death-Ligand 1
7%
Neuroblastoma Cell
7%
Neuroblastoma Cell Line
7%
Tumor
6%
Cancer
6%
Ganglioglioma
6%
Cell Line
6%
Death Receptor 5
5%
